How did BioMarin pick Brineura, this year's #FierceMadness drug-name champ?

What’s in a winning drug name? BioMarin should know. For the second time, one of its products won our #FierceMadness drug name tournament—and we've only run two naming contests. The winner is decided by voters who chose the best names from recent approvals in round-by-round match-ups leading to a final championship. In our 2015 naming contest, BioMarin's Vimizim won. Brineura, this year’s BioMarin winner, beat AstraZeneca’s Imfinzi in the final match, thanks in large part to a united and dedicated effort from BioMarin employees who embraced, in their words, a "kumbaya" approach. While the final result was skewed by a few voting bots, Brineura had already trounced other names in round after round.